@article{HBSN22509,
author = {Kessarin Thanapirom and Emmanuel A. Tsochatzis},
title = {Non-alcoholic fatty liver disease (NAFLD) and the quest for effective treatments},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {8},
number = {1},
year = {2018},
keywords = {},
abstract = {Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, affecting 24% of the population, and is impacting on global public health care with a considerable financial burden (1). NAFLD encompasses a wide disease spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis.},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/22509}
}